Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Behrooz Vaziri"'
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 13, Iss 1 (2014)
Fully mature dendritic cells (DCs) play pivotal role in inducing immune responses and converting naïve T lymphocytes into functional Th1 cells. We aimed to evaluate Listeria Monocytogenes-derived protein fractions to induce DC maturation and stimula
Externí odkaz:
https://doaj.org/article/8fecd423cb124c47b01d0ba5a480d1dd
Autor:
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, Yasaman Taslimi, Rouholah Vahabpour, Fatemeh Torkashvand, Behrooz Vaziri, Abdolhossein Rouholamini Najafabadi, Sima Rafati
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 7, p e1236 (2011)
BACKGROUND:We have demonstrated that vaccination with pDNA encoding cysteine proteinase Type II (CPA) and Type I (CPB) with its unusual C-terminal extension (CTE) can partially protect BALB/c mice against cutaneous leishmanial infection. Unfortunatel
Externí odkaz:
https://doaj.org/article/f84e2a71cb0d407f82976fc9ed6e9d5f
Publikováno v:
Journal of Nuclear Medicine. 55:1557-1564
Patients undergoing nuclear medicine procedures for cancer therapy are administered radiopharmaceuticals that emit various types of radiation. Because radiation has differential delivery to and uptake by cells in tissue, radiation exposures are often
Autor:
Alireza Vatanara, Fatemeh Torkashvand, Rouholah Vahabpour, Sima Rafati, Farnaz Zahedifard, Yasaman Taslimi, Abdolhossein Rouholamini Najafabadi, Behrooz Vaziri, Delaram Doroud
Publikováno v:
Journal of Controlled Release
Journal of Controlled Release, Elsevier, 2011, 153 (3), pp.154-62. ⟨10.1016/j.jconrel.2011.04.011⟩
Journal of Controlled Release, Elsevier, 2011, 153 (3), pp.154-62. ⟨10.1016/j.jconrel.2011.04.011⟩
International audience; Earlier generations of Leishmania vaccines have reached the third-phase of clinical trials, however none of them have shown adequate efficacy due to lack of an appropriate adjuvant. In this study, cationic solid lipid nanopart
Autor:
Roobina Boghozian, Azad Saei, Alireza Razavi, Arezoo Jamali, Jamshid Hadjati, Reza Mirzaei, Behrooz Vaziri
Publikováno v:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 123(9)
Dendritic cells (DCs) play a crucial role in the initiation of adaptive immune responses against tumor cells. We recently found that protein components of Toxoplasma gondii (T. gondii) could mature DCs efficiently. Therefore, in this study, we aimed
Autor:
Abdolhossein Rouholamini Najafabadi, Farnaz Zahedifard, Alireza Vatanara, Fatemeh Torkashvand, Sima Rafati, Yasaman Taslimi, Delaram Doroud, Rouholah Vahabpour, Behrooz Vaziri
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Public Library of Science, 2012, 5 (7), pp.e1236. ⟨10.1371/journal.pntd.0001236⟩
PLoS Neglected Tropical Diseases, Vol 5, Iss 7, p e1236 (2011)
PLoS Neglected Tropical Diseases, Public Library of Science, 2012, 5 (7), pp.e1236. ⟨10.1371/journal.pntd.0001236⟩
PLoS Neglected Tropical Diseases, Vol 5, Iss 7, p e1236 (2011)
Background We have demonstrated that vaccination with pDNA encoding cysteine proteinase Type II (CPA) and Type I (CPB) with its unusual C-terminal extension (CTE) can partially protect BALB/c mice against cutaneous leishmanial infection. Unfortunatel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb377e12b03905d1d0785872f25b451d
https://hal-riip.archives-ouvertes.fr/pasteur-00786600
https://hal-riip.archives-ouvertes.fr/pasteur-00786600
Autor:
Minoo Ahmadinejad, Hamid Hoorfar, Hassan Abolghassemi, B Mehrvar, Mohammad Baghaeipour, Behrooz Vaziri, R. Fayazfar, NB Mirbehbahhani, R. Heshmat, F Mahbodi, Mohammad Faranoush, K Kaymar, Peyman Eshghi, Babak Khoein, Mehran Karimi, Dehdezi B Keikhaei, Gh. Toogeh, Majid Naderi, Mohammadreza Managhchi
Publikováno v:
Blood. 124:4299-4299
Introduction: Concentrated factor VIII replacement therapy in severe hemophilia prevents disabling arthropathy, life-threatening bleeding, improves health related quality of life and increase life expectancy. Patients with neutralizing antibodies (in